>> The following article was written by Dr. Zoltan Kemeny PhD, President of Immune Sentry, Ltd. Doctor Kemeny being born, raised and educated in Hungary is a co-inventor, the product architect and lead engineer of the product design team. Here in his own words is an explanation of how and why the ImmunOnOne can promote natural healing.    

How the ImmunOnOne Magnetic Therapy device works

The ImmunOnOne (Model No. ISC-101) emits pulsed calming, hemoglobin harmonic photons, electromagnetic fields, and induced galvanic currents, all three elements are considered part of the magnetic therapy stimulus.

The ImmunOnOne is programmed to emit the necessary pulse packages the body needs to stimulate natural self healing. It conditions the treatment points to select and pick up the right stimulus by resonance. The treatment points ignore pulses to which they are incapable of resonating. Such redundant pulses pass harmlessly. In other words, the emission intensity is low enough to avoid harming you but still strong enough to heal.

The ImmunOnOne emits color lights and rotary magnetic fields. The super-bright diode (SBD) on each side of the green is an infrared light-emitting diode (LED), which emits light in the non-visible wavelength, thus its flashing is not visible but felt by its gentle heat emission. The light wavelengths correspond to round multiples of the color of hemoglobin, which gives the red color of the blood. The rotary magnetic field induces galvanic current under the Treatment Point. The emitted fields have sufficient energy to be able to trigger a self healing response avalanche through the treatment points, which are at a low electrical potential relative to their surroundings. The pulse timing harmonizes with the bodies natural frequencies. Every time the ON/OFF switch is pushed a treatment program starts and ends automatically after 5 minutes.

 

Why does it work? 

According to the ImmunOnOne theory: Pulses of the ImmunOnOne assist in regulating healthy levels of white blood counts, including immune sentry cell counts. It stimulates endocrine gland secretion and raises levels of anti-body, gamma globulins, specific hormones and prostaglandin, which all fight pathogens. This is the mechanism by which health maintenance works using ImmunOnOne.

Pulses of the ImmunOnOne stimulate the secretion of endorphins, which are a thousand times stronger than morphine and act as the body’s own natural pain killer. It also can affect certain neurotransmitter levels, including but not limited to serotonin and noradrenalin. Furthermore, it can block neurotransmitter gate impulses. Gate theory says that pain perception is controlled by a part of the nervous system. This regulates the neural impulse, which is felt as pain. When the neural gate is overloaded with impulses, it closes to protect itself from being damaged. This in turn prevents some of the impulses passing through, thereby lessens or blocks pain. This is the mechanism by which pain control works using ImmunOnOne.

Pulses of the ImmunOnOne assist the body to release vasodilator, including histamine, thus is capable of helping the dilation of blood vessels regulating low blood pressure conditions. Also, the release of other mediators control blood vessel constriction and thereby alleviate high blood pressure related symptoms. This is the mechanisms by which allergy and mood control works using ImmunOnOne.

Pulses of the ImmunOnOne stimulate gradual build up of immune and immunon cells. The immunon theory, the modern quantum theory of immunology, asserts that immune cells need to achieve certain size in coupled groups before acquiring capacity to attack pathogens. For instance, “the minimal unit of cross linked receptor plus antigen complex, required for activation of the B-cells, termed immunon”, is 12-16 — depending on bio-chemistry involved — and the group needs to be with a stabile bond. This is the mechanism by which ailment alleviation and accelerated recovery from illness works using ImmunOnOne.

The immunon theory explains why self healing assisted by ImmunOnOne treatments need repetition of a treatment as therapy when assisting in betterment or cure of chronic and functional ailments. That is, the required cell formations need time, which varies by person and personal conditions, thus difficult to predict with certainty.

The immunon theory also explains why self healing assisted by ImmunOnOne treatments is an unsteady process and cure may appear to some patients as delayed or ineffective for some time and then suddenly the body heals itself and the ailment may never return. That is, the stability of the required cell groups and antigen chemistry is not automatically ensured but rather formed randomly by trial and error and cure cannot even start until the sufficient number of the needed cells are formed in a stable group and thus are ready to attack pathogens.

This explains why the ImmunOnOne appears miraculous and divine to some, sometimes and less effective to others at other times. That is how self healing is. The ImmunOnOne only assists in and thus accelerates self healing by induction. The main purpose of the ImmunOnOne is to keep your immune system strong and responsive, so you can avoid becoming ill.

Since the immune system and its neural control is very complex and needs years to study, so rather then explaining in detail, for more explanation, we direct the user to other open information sources.

Why it may take time and repetition to work

Perhaps the most plausible explanation is offered by the immunon theory, the modern quantum theory of immunology. It asserts that immune cells need to achieve certain size in coupled groups before acquiring enough capacity to attack pathogens. For instance, “the minimal unit of cross linked receptor plus antigen complex, required for activation of the B-cells, termed immunon”, is 12 -16 depending on the bio-chemistry involved; the group needs to be with a stabile bond. The first of the figures below (used by permission) illustrates a stable group in formation; the second a stable complete and thus able-formation or closed-loop; and the third illustrates an un-stable group in progress of build-up, but ultimately unable to fight disease. Thus, one can appreciate the time needed to form any such build-ups and selections, which can be aided by the repeated ImmunOnOne magnetic therapy treatments.

In this diagrammatic representation of the immune concept, the wedge shaped objects represent mobile receptor protein molecules containing single binding sites (circles). One common antigen receptor is the streptavidin peroxadase. The heavy dark lines represent polyacrylamide molecules with substituted Dnp groups, shown as solid lines with solid circles. The length of the ployacryamide molecules and the number of Dnp groups are the same for preparations on left and middle but are different for preparation on the right. Receptor proteins aggregate spontaneously but can be helped or forced to aggregate by external impulses, like the ones the ImmunOnOne is aiming at and able to force the formation of complete immunon (center). Other formations and linkages, for various reasons are incapable to form immunons or, for being unstable, can quickly disintegrate and thus are not capable to fight pathogens. The ImmunOnOne virtually can force the described molecular buildups, molecule-by-molecule, by its programmed rotary magnetic pulsation around its pulsed induced galvanic current axis.

In short, especially with acute persisting ailments, the treatment requires patience and no expectation of instantaneous improvement. It is not uncommon however that certain problems become somewhat even worse before getting any better, but they will do so suddenly due to the quantum nature of immunon formations, and they'll be gone for good. This may appear as spontaneous healing, or even a miracle. Fortunately, the fix is typically much quicker than the development of the chronic problem itself. Acute and instant pain, allergy and other ailments can however be helped virtually by instant or one or few treatments only as instructed in the Immune Sentry Treatments.

For more detailed explanation please see: Proc. Natl. Acad. Sci. USA Vol. 73, No. 10, pp. 3671-3675, October 1976; Immunology Molecular determinants of immunogenicity: The immunon model of immune response (polyacrylamide/dinitrophenyl-/receptor linkage); H. M. DINTZIS*, R. Z. DINTZIS*t, AND B. VOGELSTEIN*, *Department of Biophysics and t Department of Anatomy, Johns Hopkins University School of Medicine, 725 North Wolfe Street, Baltimore, Maryland 21205 or search it at the http://www.pnas.org/ site by PNAS (the Proceedings of the National Academy of Sciences of the United States of America).